Diagnostic performance of fatty liver index reveals limitations in identifying hepatic steatosis in HIV population, suggesting inadequate reliability.
FLI demonstrates substantial limitations as a screening tool for HS in people living with HIV, missing nearly half of CAP-defined cases. The poor concordance with CAP and particularly weak performance in lean individuals-who represent a significant proportion of PWH-indicate that FLI cannot reliably identify HS in this population and should not be used as a standalone diagnostic tool.
No takes yet. Share an insight, caveat, or question.
Cordie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: